These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 36585213)

  • 1. An
    Furini HH; Fukushima KSSQ; DE Nóbrega M; DE Souza MF; Rodrigues MRS; DE Mattos BB; Guembarovski RL; Fuganti PE; Simão ANC; Flauzino T; Cólus IMS
    Anticancer Res; 2023 Jan; 43(1):369-379. PubMed ID: 36585213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphic variants of the CASP3, CASP9, BCL-2 and NKX3-1 genes as candidate markers for prostate cancer susceptibility and poor prognosis.
    de Souza MR; de Souza MF; de Nóbrega M; Cilião HL; Dos Reis MB; Fuganti PE; Cólus IMS
    Mol Biol Rep; 2022 Sep; 49(9):9079-9087. PubMed ID: 35708863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases.
    FitzGerald LM; Zhao S; Leonardson A; Geybels MS; Kolb S; Lin DW; Wright JL; Eeles R; Kote-Jarai Z; Govindasami K; Giles GG; Southey MC; Schleutker J; Tammela TL; Sipeky C; Penney KL; Stampfer MJ; Gronberg H; Wiklund F; Stattin P; Hugosson J; Karyadi DM; Ostrander EA; Feng Z; Stanford JL
    Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):228-237. PubMed ID: 29298992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of polymorphisms of PTEN, AKT1, PI3K, AR, and AMACR genes in patients with prostate cancer.
    Nóbrega M; Cilião HL; Souza MF; Souza MR; Serpeloni JM; Fuganti PE; Cólus IMS
    Genet Mol Biol; 2020 Jun; 43(3):e20180329. PubMed ID: 32484847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of O
    Zhang W; Liu M; Li Y; Song S; Li K; Ma Y
    Pathol Oncol Res; 2020 Apr; 26(2):1201-1209. PubMed ID: 31190217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MGMT Ile143Val polymorphism, dietary factors and the risk of breast, colorectal and prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk study.
    Loh YH; Mitrou PN; Bowman R; Wood A; Jeffery H; Luben RN; Lentjes MA; Khaw KT; Rodwell SA
    DNA Repair (Amst); 2010 Apr; 9(4):421-8. PubMed ID: 20096652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMAD7 and MGMT genotype variants and cancer incidence in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk Study.
    Loh YH; Mitrou PN; Wood A; Luben RN; McTaggart A; Khaw KT; Rodwell SA
    Cancer Epidemiol; 2011 Aug; 35(4):369-74. PubMed ID: 21075068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of MGMT in malignant pleural mesothelioma occurs in a subset of patients and is associated with the T allele of the rs16906252 MGMT promoter SNP.
    Kristensen LS; Nielsen HM; Hager H; Hansen LL
    Lung Cancer; 2011 Feb; 71(2):130-6. PubMed ID: 20627446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival.
    Fogli A; Chautard E; Vaurs-Barrière C; Pereira B; Müller-Barthélémy M; Court F; Biau J; Pinto AA; Kémény JL; Khalil T; Karayan-Tapon L; Verrelle P; Costa BM; Arnaud P
    Carcinogenesis; 2016 Feb; 37(2):169-176. PubMed ID: 26717998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide.
    Rapkins RW; Wang F; Nguyen HN; Cloughesy TF; Lai A; Ha W; Nowak AK; Hitchins MP; McDonald KL
    Neuro Oncol; 2015 Dec; 17(12):1589-98. PubMed ID: 25910840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of MGMT polymorphisms rs12917 and rs11016879 in head and neck cancer risk and prognosis.
    Kiczmer P; Prawdzic Seńkowska A; Strzelczyk JK; Szydło B; Biernacki K; Osadnik T; Krakowczyk Ł; Ostrowska Z
    Acta Biochim Pol; 2018; 65(1):87-92. PubMed ID: 29370316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma.
    Doecke J; Zhao ZZ; Pandeya N; Sadeghi S; Stark M; Green AC; Hayward NK; Webb PM; Whiteman DC;
    Int J Cancer; 2008 Jul; 123(1):174-80. PubMed ID: 18386788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotyping of the C>T allele of rs16906252, predictor of O16-methylguanine-DNA methyltransferase (MGMT) promoter methylation status, in erosive atrophic lesions of oral lichen planus.
    Sánchez-Siles M; Aliaga-Sánchez A; Medina S; Adoamnei E; Fernández-Ruiz JA; Pelegrín-Hernández JP; Corno-Caparrós A; Rosa-Salazar V; Camacho-Alonso F
    Int J Dermatol; 2019 Sep; 58(9):1078-1082. PubMed ID: 31373397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The T genotype of the MGMT C>T (rs16906252) enhancer single-nucleotide polymorphism (SNP) is associated with promoter methylation and longer survival in glioblastoma patients.
    McDonald KL; Rapkins RW; Olivier J; Zhao L; Nozue K; Lu D; Tiwari S; Kuroiwa-Trzmielina J; Brewer J; Wheeler HR; Hitchins MP
    Eur J Cancer; 2013 Jan; 49(2):360-8. PubMed ID: 22975219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of MGMT promoter methylation in normal individuals is strongly associated with the T allele of the rs16906252 MGMT promoter single nucleotide polymorphism.
    Candiloro IL; Dobrovic A
    Cancer Prev Res (Phila); 2009 Oct; 2(10):862-7. PubMed ID: 19789298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants in MGMT and risk of lung cancer in Southeastern Chinese: a haplotype-based analysis.
    Hu Z; Wang H; Shao M; Jin G; Sun W; Wang Y; Liu H; Wang Y; Ma H; Qian J; Jin L; Wei Q; Lu D; Huang W; Shen H
    Hum Mutat; 2007 May; 28(5):431-40. PubMed ID: 17285603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MGMT gene variants, temozolomide myelotoxicity and glioma risk. A concise literature survey including an illustrative case.
    Altinoz MA; Elmaci I; Bolukbasi FH; Ekmekci CG; Yenmis G; Sari R; Sav A
    J Chemother; 2017 Aug; 29(4):238-244. PubMed ID: 28436299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of influence of MGMT codon Leu84Phe and codon Ileu143Val polymorphisms on esophageal cancer risk in the Kashmir Valley.
    Shah MA; Shaff SM; Lone GN; Jan SM
    Asian Pac J Cancer Prev; 2012; 13(7):3047-52. PubMed ID: 22994708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
    Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS
    Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MGMT promoter single-nucleotide polymorphism rs1625649 had prognostic impact on patients with MGMT methylated glioblastoma.
    Hsu CY; Ho HL; Lin SC; Ho TD; Ho DM
    PLoS One; 2017; 12(10):e0186430. PubMed ID: 29036186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.